PAIN-LESS: Understanding and Alleviating Pain for Cancer Patients in Academic and Community Hospitals
1 other identifier
observational
466
1 country
1
Brief Summary
This study will increase knowledge of patient preferences for pain treatments, and improve the ability to meet patients pain management needs. This study will assess patient attitudes towards underutilized treatments and identify technologies to increase awareness of such treatments. This study also demonstrate the feasibility of using the Penn Cancer Network in future clinical and cancer control research and better understand how to effectively raise patients awareness of supportive cancer services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 23, 2015
CompletedFirst Posted
Study publicly available on registry
September 24, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2015
CompletedJuly 23, 2019
July 1, 2019
1.1 years
June 23, 2015
July 22, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Number of subjects providing completed surveys
1 year
Interventions
Eligibility Criteria
Cancer Patients
You may qualify if:
- Age 18 or older; Have a primary diagnosis of cancer;
- Have a Karnofsky functional score of 60 or greater (i.e. ambulatory);
- Understand written English;
- Verbally indicate to the RA/RN that they feel physically well enough to complete a survey at the time of approach;
- Report experiencing nonzero pain (on a scale of 0-10) in the last seven days
You may not qualify if:
- An inability to understand the requirements of the survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Mao, MD
Abramson Cancer Center at Penn Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2015
First Posted
September 24, 2015
Study Start
September 1, 2014
Primary Completion
September 30, 2015
Study Completion
September 30, 2015
Last Updated
July 23, 2019
Record last verified: 2019-07